Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
Data Collection I01:30

Data Collection I

Data collection gathers information needed to make accurate judgments about a patient's present condition. During a health history interview, subjective data is collected from the patient, their caregivers, or family members, and objective data is collected through observations and physical assessment. Patients are the primary source of subjective data. Thus information gathered from patients through interviews, observations, and physical examination is primary data. Secondary sources of data...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Methods of Documentation V: CBE01:23

Methods of Documentation V: CBE

Charting by Exception, or CBE, is a method of documentation used in healthcare, particularly in nursing, that focuses on documenting only significant or abnormal findings rather than recording every detail. This approach aims to streamline the documentation process, improve efficiency, and ensure that healthcare providers can quickly identify deviations from normalcy in patient assessments.
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A scoping review on clinical and genetic diagnostic approaches for cerebral visual impairment.

Survey of ophthalmology·2025
Same author

Comparative effectiveness of combining antidiabetic medications to treat renal impairment in patients with type 2 diabetes mellitus.

Scientific reports·2025
Same author

Opioid-Related Emergency Department Visits Before and During COVID-19: Association with Community-Level Factors.

HCA healthcare journal of medicine·2024
Same author

Potential impact of blood cholesterol guidelines on statin treatment in the U.S. population using interrupted time series analysis.

BMC cardiovascular disorders·2024
Same author

Decision rules for personalized statin treatment prescriptions over multi-objectives.

Experimental biology and medicine (Maywood, N.J.)·2024
Same author

Machine Learning for Risk Prediction of Recurrent AKI in Adult Patients After Hospital Discharge.

Studies in health technology and informatics·2024
Same journal

LabSage: Structural-Semantic Decoupling for Enhanced Retrieval-Augmented Generation in Clinical Laboratories.

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science·2026
Same journal

Evaluating Representation Embeddings from LLMs and Time-Series Foundation Models for Wearable Accelerometer-Based Health Prediction.

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science·2026
Same journal

ClinNoteAgents: An LLM Multi-Agent System for Predicting and Interpreting Heart Failure 30-Day Readmission from Clinical Notes.

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science·2026
Same journal

Mapping the Storm: Linking Tornado Paths to Emergency Room Surges Through Geocoded Patient Data.

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science·2026
Same journal

Multi-Modal Deep Learning-Based Model to Predict Burkitt Lymphoma Recurrence.

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science·2026
Same journal

A Multi-Model LLM Consensus Framework to Identify EHR-Predictable Eligibility Criteria in NSCLC Immunotherapy Trials.

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science·2026
See all related articles

Related Experiment Video

Updated: May 26, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

A framework and standardized methodology for developing minimum clinical datasets.

Piper A Svensson-Ranallo1, Terrence J Adam, François Sainfort

  • 1Institute for Health Informatics, University of Minnesota, Minneapolis, MN;

AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science
|January 3, 2012
PubMed
Summary
This summary is machine-generated.

Developing a high-quality minimum clinical dataset (MCDS) is crucial for healthcare data exchange. This study presents a streamlined methodology to guide the development of robust MCDS, addressing a gap in empirical evidence.

More Related Videos

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

Related Experiment Videos

Last Updated: May 26, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

Area of Science:

  • Health Informatics
  • Data Management
  • Clinical Documentation

Background:

  • The minimum dataset (MDS) concept is vital in modern healthcare.
  • Minimum clinical datasets (MCDS) are increasingly discussed amid electronic health record adoption.
  • Lack of a unified definition and empirical evidence for MCDS development exists.

Purpose of the Study:

  • To address the scarcity of empirical evidence on MCDS development methods.
  • To present a streamlined approach for creating high-quality MCDS.
  • To provide a coherent methodology and framework for MCDS development.

Main Methods:

  • Literature review on existing MDS and MCDS concepts.
  • Development of a novel, streamlined methodology for MCDS creation.
  • Framework design for systematic MCDS development.

Main Results:

  • A coherent methodology and framework for MCDS development were established.
  • The proposed approach facilitates the creation of high-quality MCDS.
  • The study bridges the gap in empirical evidence for MCDS development.

Conclusions:

  • A structured approach is essential for effective MCDS development.
  • The presented methodology offers a practical solution for healthcare organizations.
  • This work contributes to standardizing clinical data elements for better health information exchange.